Evidence map›Paper›PMID 36935679›Full record

ReviewFrontiers in public health2023

Overview and update on cytomegalovirus-associated anterior uveitis and glaucoma.

Zifan Ye, Yumei Yang, Weishaer Ke, Yuhang Li, Kaijun Wang, Min Chen

Open access · goldFull text readReview
In one paragraph

Review in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zifan YeEye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Yumei YangShangyu People's Hospital of Shaoxing, Shaoxing, China.
Weishaer KeEye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Yuhang LiEye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Kaijun WangEye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Min ChenEye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Second Affiliated Hospital of Zhejiang University · CNShaoxing People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytomegalovirus anterior uveitis is the most common ocular inflammatory disease caused by cytomegalovirus infection. It mainly occurs in middle-aged males with competent immunologic function, and the incidence is higher in Asia. The clinical manifestations vary from Posner-Schlossman syndrome and corneal endotheliitis to Fuchs uveitis syndrome, and are often accompanied by intraocular hypertension. Secondary glaucoma is a potentially blinding ocular complication with a pathogenesis that includes complicated immunological factors, intraocular inflammation, different types of angle abnormalities, and the administration of steroids, which may result in physical discomfort and visual impairment. Diagnostic tests, such as the polymerase chain reaction, optical coherence tomography, ocular microscopy, and confocal microscopy, might help in identifying anterior uveitis caused by other viruses. Combinations of antiviral medications and anti-inflammatory agents are effective treatments. If pharmacological therapy cannot reduce intraocular pressure or slow the progression of glaucomatous optic neuropathy, surgical intervention is required as a last resort.

Indexed as

Cytomegalovirus InfectionsGlaucomaUveitis, AnteriorCytomegalovirusEyeHumansMaleMiddle Agedanterior uveitisantiviral therapycytomegalovirusglaucomaintraocular pressure management

Identifiers

PMID36935679
PMCPMC10014866
OpenAlexW4322743656

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read67
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.